Current Edition

clinical

Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer

Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1 against heavily pretreated HER2-positive breast …

Continue Reading →
2018

ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overall survival …

Continue Reading →
3

Early findings from a phase 3 clinical trial report promising results

The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma. Dendritic cells …

Continue Reading →